Prolonged duration of sleep is associated with a higher risk of cognitive decline among patients with mild cognitive impairment (MCI) and early Alzheimer’s disease (AD), according to a study presented at the Singapore Health & Biomedical Congress (SHBC) 2018.
The question of whether to exercise or not typically emerges in the setting of chronic pain, as patients fear that moving may contribute to exacerbate their condition. Yet, exercise does exert hypoalgesic effects on chronic pain conditions however variable these effects are, according to a senior physiotherapist who spoke at the Singapore Health & Biomedical Congress 2018.
Chronic noncancer pain can be treated with the use of opioid without necessarily causing addiction or abuse by the patient, according to a study presented at the Singapore Health and Biomedical Congress (SHBC) 2018.
Unhealthy eating behaviours appear to be relatively common among prediabetics in Singapore, Dr Wee Wei Keong said during an oral presentation at the recently concluded 16th Singapore Health and Biomedical Conference (SHBC 2018).
Glycated haemoglobin (HbA1c) is as effective as fasting plasma glucose (FPG) in screening for and diagnosing diabetes, said Dr Wei-Yen Lim, of the Department of Clinical Epidemiology of the Tan Tock Seng Hospital, at the recently concluded Singapore Health and Biomedical Congress (SHBC) 2018.
Commercial wrist brace can be used as a safe alternative to custom-made thermoplastic splint in the management of acute and stable distal radius fractures, with both orthoses providing adequate protection and support and without there being any incidence of adverse event or complication, according to the results of a trial presented at the Singapore Health & Biomedical Congress 2018.
Adherence to inhaled corticosteroids (ICS) among older adults with asthma is relatively low at 40.9 percent, according to a study presented at the recently concluded Singapore Health and Biomedical Congress (SHBC) 2018. Perceived illness timeline and medication beliefs correlate with adherence.
Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.